New Centre Enhances Immunotherapy Studies
On 1st May 2026, Monash University, in collaboration with The Alfred, announced the establishment of The Australian Cancer Research Foundation Centre for Dynamic Immuno-Oncology (CDIO) located in Melbourne’s south-east. This centre aims to advance cancer immunotherapy research and clinical trials.
Headquartered at The Alfred’s Paula Fox Melanoma and Cancer Centre, the CDIO is co-located with Monash University’s Alfred campus. The focus will be on real-time monitoring of patient responses to immunotherapy to enhance early detection of anti-tumour benefits and side-effects.
Professor Sharon Pickering, Monash Vice-Chancellor and President, said, “The CDIO’s development was made possible through funding from the Australian Cancer Research Foundation, its donors, and the National Imaging Facility. The CDIO will bring together cutting-edge technology and leading experts to accelerate the effectiveness of immunotherapies.”
Technological Advancements at the CDIO
Advanced equipment such as the $24 million Quadra PET/CT scanner at The Alfred will be utilised by the centre. This total-body scanner enables earlier detection of small cancers, faster scans, and real-time treatment assessments, enhancing both research and clinical trial capabilities.
Highlighting the importance of this research, Kerry Strydom, Chief Executive of the Australian Cancer Research Foundation, stated, “The CDIO will track immune responses, improving the safety and effectiveness of immune-based cancer treatments.”
Through scientific discovery and real-world impact, the partnership between Monash University, The Alfred, and Cabrini aims to transform cancer care. Professor Mark Shackleton, head of the new Monash Department of Cancer Medicine, emphasised the collaboration’s potential to innovate cancer care in Victoria and beyond.
Field trials and research at the CDIO are set to provide enhanced access to breakthrough treatments for the 1.2 million residents in the Bayside Health corridor. According to Bayside Health Alfred Care Group Chief Executive Adjunct Professor Simone Alexander, this initiative positions Victoria at the forefront of global immunology research.
As part of Monash University’s new Department of Cancer Medicine, the CDIO aims to advance cancer research and clinical trials across Melbourne’s south-east and regional Victoria. Collaborations among researchers, clinicians, and data scientists will drive faster and more equitable improvements in cancer care.
The Australian Cancer Research Foundation is excited to support this transformative research program. Advanced immune-monitoring technologies at the CDIO will track immune responses, enabling safer and more effective cancer treatments. This aligns with the foundation’s vision of transforming outcomes for people diagnosed with cancer.
Last updated: 1 May 2026, 11:19 pm
